Cytek Biosciences, Inc. (CTKB)

NASDAQ

$5.42

$+0.15

(+2.86%)

Regular Market

Cytek Biosciences, Inc. (CTKB) Live Price Chart

Last updated: ⁦2026-10-20 15:54:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cytek Biosciences, Inc. (CTKB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $5.42, with a market capitalization of $682.41M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.31 to $6.21. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$682.41M
Open	$5.29
Day's High	$28.70
Day's Low	$2.37
Previous Close	$5.25
Volume	139.01K
Average Volume	1.12M
P/E Ratio	--
52-Week High	$6.21
52-Week Low	$3.31
Dividend Yield	--
Earnings Date	--

Cytek Biosciences, Inc. (CTKB) Stock Price Today

Cytek Biosciences, Inc. (CTKB) is currently trading at $5.42 as of 2026-10-20 15:53:00, up 3.18% ($0.17) from the previous close of $5.25

During today's regular trading session, CTKB has traded between $2.37 and $28.70, with a trading volume of 139.01K shares. The current price is near the lower end of today's range.

Cytek Biosciences, Inc. (CTKB) 7-Day Stock Price Change

Over the past seven days, Cytek Biosciences, Inc. (CTKB) moved from $5.43 to $5.42, representing a decline of 0.24% ($0.01).

The stock traded between $5.12 and $5.56 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 1.44 million shares, down versus the previous seven-day period, indicating lower trading activity.

CTKB 52-Week Price Position

Position in Range: 72.7%

52W Low$3.31

52W High$6.21

CTKB is currently trading at $5.42, placing it 72.7% of the way from its 52-week low of $3.31 to its 52-week high of $6.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cytek Biosciences, Inc. (CTKB)?

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Cytek Biosciences, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	702
Exchange	NASDAQ
Company Website	https://www.cytekbio.com

How to Buy Cytek Biosciences, Inc. (CTKB) Stock on MEXC

Eligible investors can buy real shares of Cytek Biosciences, Inc. (CTKB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CTKB and Place Your Order

Open the RealStocks trading page and search for CTKB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cytek Biosciences, Inc. (CTKB) stock price today?

Cytek Biosciences, Inc. (CTKB) is currently trading at $ 5.42, up 3.18% ($0.17) from the previous close of $ 5.25. Intraday prices update in real time during regular trading hours.

2.Is CTKB stock going up or down today?

As of 2026-10-20 15:53:00, CTKB is trading at $ 5.42, up 3.18% ($0.17) from its previous close of $ 5.25. The stock has traded between $ 2.37 and $ 28.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is CTKB pre-market price?

As of 2026-10-20 15:53:00, CTKB is trading at $ 5.35 in pre-market trading, up 1.90% ($0.10) from the previous close of $ 5.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CTKB after-hours price?

As of 2026-10-20 15:53:00, CTKB is trading at $ 5.26 in after-hours trading, up 0.10% ($0.00) from the regular-session close of $ 5.25. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CTKB stock trading now?

CTKB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CTKB sit relative to its 52-week high and low?

Over the past 52 weeks, CTKB has traded between a low of $ 3.31 and a high of $ 6.21. At $ 5.42, the stock is positioned 72.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cytek Biosciences, Inc. in?

Cytek Biosciences, Inc. (CTKB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cytek Biosciences, Inc.'s market capitalization and where is it listed?

Cytek Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 682.41M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CTKB valued in terms of P/E ratio and EPS?

CTKB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.62. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cytek Biosciences, Inc. pay a dividend?

Cytek Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.